Journal of Biological Chemistry · 2004 · 69 citations · 25 references
Life SciencesBiochemistryMolecular BiologyCellular MetabolismMetabolic RegulationMetabolismAtp SynthesisEnergy MetabolismMetabolic SignalingNicotinamide Adenine Dinucleotide MetabolismOxidative PhosphorylationRedox MetabolismAdenosine Monophosphate-activated Protein Kinase PathwayAdenosine Monophosphate-activated Protein Kinase SignalingCellular Energy SensingEnzyme Activity RegulationNad+ Redox BalanceNadh Metabolic RegulationNadh OxidationRedox Potential Changes
AMP-activated protein kinase (AMPK) serves as an energy-sensing protein kinase that is activated by a variety of metabolic stresses that lower cellular energy levels. When activated, AMPK modulates a network of metabolic pathways that result in net increased substrate oxidation, generation of reduced nucleotide cofactors, and production of ATP. AMPK is activated by a high AMP:ATP ratio and phosphorylation on threonine 172 by an upstream kinase. Recent studies suggest that mechanisms that do not involve changes in adenine nucleotide levels can activate AMPK. Another sensor of the metabolic state of the cell is the NAD/NADH redox potential. To test whether the redox state might have an effect on AMPK activity, we examined the effect of β-NAD and NADH on this enzyme. The recombinant T172D-AMPK, which was mutated to mimic the phosphorylated state, was activated by β-NAD in a dose-dependent manner, whereas NADH inhibited its activity. We explored the effect of NADH on AMPK by systematically varying the concentrations of ATP, NADH, peptide substrate, and AMP. Based on our findings and established activation of AMPK by AMP, we proposed a model for the regulation by NADH. Key features of this model are as follows. (a) NADH has an apparent competitive behavior with respect to ATP and uncompetitive behavior with respect to AMP resulting in improved binding constant in the presence of AMP, and (b) the binding of the peptide is not significantly altered by NADH. In the absence of AMP, the binding constant of NADH becomes higher than physiologically relevant. We conclude that AMPK senses both components of cellular energy status, redox potential, and phosphorylation potential. AMP-activated protein kinase (AMPK) serves as an energy-sensing protein kinase that is activated by a variety of metabolic stresses that lower cellular energy levels. When activated, AMPK modulates a network of metabolic pathways that result in net increased substrate oxidation, generation of reduced nucleotide cofactors, and production of ATP. AMPK is activated by a high AMP:ATP ratio and phosphorylation on threonine 172 by an upstream kinase. Recent studies suggest that mechanisms that do not involve changes in adenine nucleotide levels can activate AMPK. Another sensor of the metabolic state of the cell is the NAD/NADH redox potential. To test whether the redox state might have an effect on AMPK activity, we examined the effect of β-NAD and NADH on this enzyme. The recombinant T172D-AMPK, which was mutated to mimic the phosphorylated state, was activated by β-NAD in a dose-dependent manner, whereas NADH inhibited its activity. We explored the effect of NADH on AMPK by systematically varying the concentrations of ATP, NADH, peptide substrate, and AMP. Based on our findings and established activation of AMPK by AMP, we proposed a model for the regulation by NADH. Key features of this model are as follows. (a) NADH has an apparent competitive behavior with respect to ATP and uncompetitive behavior with respect to AMP resulting in improved binding constant in the presence of AMP, and (b) the binding of the peptide is not significantly altered by NADH. In the absence of AMP, the binding constant of NADH becomes higher than physiologically relevant. We conclude that AMPK senses both components of cellular energy status, redox potential, and phosphorylation potential. The mammalian 5′-AMP-activated protein kinase (AMPK) 1The abbreviations used are: AMPK, AMP-activated protein kinase; WT, wild type; Ni-NTA, nickel-nitrilotriacetic acid; MALDI-MS, matrix-assisted laser desorption ionization mass spectrometry; SAMS, HMRSAMSGLHLVKRR.1The abbreviations used are: AMPK, AMP-activated protein kinase; WT, wild type; Ni-NTA, nickel-nitrilotriacetic acid; MALDI-MS, matrix-assisted laser desorption ionization mass spectrometry; SAMS, HMRSAMSGLHLVKRR. serves as an energy-sensing protein kinase. It is activated by a variety of metabolic stresses that lower cellular energy levels. These include exercise, nutrient starvation, ischemia/hypoxia, heat shock, and metabolic poisoning (1Hardie D.G. Carling D. Carlson M. Ann. Rev. Biochem. 1998; 67: 821-855Crossref PubMed Scopus (1270) Google Scholar, 2Kemp B.E. Mitchelhill K.I. Stapleton D. Michell B.J. Chen Z.P. Witters L.A. Trends Biochem. Sci. 1999; 24: 22-25Abstract Full Text Full Text PDF PubMed Scopus (461) Google Scholar, 3Ruderman N.B. Saha A.K. Vavvas D. Witters L.A. Am. J. Physiol. 1999; 276: E1-E18Crossref PubMed Google Scholar, 4Winder W.W. Hardie D.G. Am. J. Physiol. 1999; 277: E1-E10PubMed Google Scholar). AMPK is also activated by a number of pharmacological interventions. AICAR (5-aminoimidazole-4-carboxamide 1-b-d-ribonucleoside), which is converted to an AMP analog upon entering the cells, is a commonly used tool for activating AMPK (5Henin N. Vincent M-F. Van den berghe G Biochim. Biophys. Acta. 1996; 1290: 197-203Crossref PubMed Scopus (94) Google Scholar). Leptin (6Minokoshi Y. Kim Y.B. Peroni O.D. Fryer L.G. Muller C. Carling D. Kahn B.B. Nature. 2002; 415: 339-343Crossref PubMed Scopus (1660) Google Scholar), adiponectin (7Yamauchi T. Kamon J. Minokoshi Y. Ito Y. Waki H. Uchida S. Yamashita S. Noda M. Kita S. Ueki K. Eto K. Akanuma Y. Froguel P. Foufelle F. Ferre P. Carling D. Kimura S. Nagai R. Kahn B.B. Kadowaki T. Nat. Med. 2002; 8: 1288-1295Crossref PubMed Scopus (3417) Google Scholar), metformin (8Fryer L.G. Parbu-Patel A. Carling D. J. Biol. Chem. 2002; 277: 25226-25232Abstract Full Text Full Text PDF PubMed Scopus (907) Google Scholar, 9Hawley S.A. Gadalla A.E. Olsen G.S. Hardie D.G. Diabetes. 2002; 51: 2420-2425Crossref PubMed Scopus (572) Google Scholar), and rosiglitazone (8Fryer L.G. Parbu-Patel A. Carling D. J. Biol. Chem. 2002; 277: 25226-25232Abstract Full Text Full Text PDF PubMed Scopus (907) Google Scholar) activate AMPK through poorly characterized mechanisms that may not involve energy depletion. The activation of AMPK stimulates fatty acid oxidation, hexokinase activity, and uptake of glucose into skeletal muscle, which generates reduced nucleoside co-factors and ATP, and represses hepatic gluconeogenic and fatty acid synthesis enzymes, which consume them (10Kemp B.E. Stapleton D. Campbell D.J. Chen Z.P. Murthy S. Walter M. Gupta A. Adams J.J. Katsis F. Van Denderen B. Jennings I.G. Iseli T. Michell B.J. Witters L.A. Biochem. Soc. Trans. 2003; 31: 162-168Crossref PubMed Google Scholar). AMPK is a heterotrimeric complex consisting of a catalytic (α) subunit and two regulatory subunits (β and γ) (11Dyck J.R. Gao G. Widmer J. Stapleton D. Fernandez C.S. Kemp B.E. Witters L.A. J. Biol. Chem. 1996; 271: 17798-17803Abstract Full Text Full Text PDF PubMed Scopus (162) Google Scholar). The isoforms of all three subunits have been identified including two isoforms of the catalytic subunit, α1 and α2 (9Hawley S.A. Gadalla A.E. Olsen G.S. Hardie D.G. Diabetes. 2002; 51: 2420-2425Crossref PubMed Scopus (572) Google Scholar), two of the regulatory subunits, β1 and β2, and three of the regulatory subunits, γ1, γ2, and γ3 (12Cheung P.C. Salt I.P. Davies S.P. Hardie D.G. Carling D. Biochem. J. 2000; 346: 659-669Crossref PubMed Scopus (527) Google Scholar). The formation of the trimeric complex is necessary for optimal kinase activity (11Dyck J.R. Gao G. Widmer J. Stapleton D. Fernandez C.S. Kemp B.E. Witters L.A. J. Biol. Chem. 1996; 271: 17798-17803Abstract Full Text Full Text PDF PubMed Scopus (162) Google Scholar, 13Woods A. Salt I. Scott J. Hardie D.G. Carling D. FEBS Lett. 1996; 397: 347-351Crossref PubMed Scopus (230) Google Scholar). Numerous studies have shown that changes in the cellular energy state activate AMPK through mechanisms involving an AMP allosteric regulation and phosphorylation by an upstream kinase on threonine residue 172 within the catalytic α subunit (14Hawley S.A. Davison M. Woods A. Davies S.P. Beri R.K. Carling D. Hardie D.G. J. Biol. Chem. 1996; 271: 27879-27888Abstract Full Text Full Text PDF PubMed Scopus (1003) Google Scholar). This kinase has been recently identified as LKB1 (15Woods A. Johnstone S.R. Dickerson K. Leiper F.C. Fryer L.G.D. Neumann D. Schlattner U. Wallimann T. Carlson M. Carling D. Curr. Biol. 2003; 13: 2004-2008Abstract Full Text Full Text PDF PubMed Scopus (1324) Google Scholar, 16Lizcano J.M. Goransson O. Toth R. Deak M. Morrice N.A. Boudeau J. Hawley S.A Udd L. Makela T.P. Hardie D.G. Alessi D.R EMBO J. 2004; 23: 833-843Crossref PubMed Scopus (1048) Google Scholar). Although the activation of AMPK appears to be a direct consequence of an increase in the AMP:ATP ratio as a result of metabolic stresses that deplete cellular ATP, Lopaschuk and colleagues (17Makinde A.O. Kantor P.F. Lopaschuk G.D. Mol. Cell. Biochem. 1998; 188: 49-56Crossref PubMed Scopus (86) Google Scholar) have shown that cardiac AMPK activity could be changed under conditions where significant alterations in the AMP:ATP ratio do not occur (18Beauloye C. Marsin A.S. Bertrand L. Krause U. Hardie D.G. Vanoverschelde J.L. Hue L. FEBS Lett. 2001; 505: 348-352Crossref PubMed Scopus (111) Google Scholar). Moreover, Frederich and Balschi (19Frederich M. Balschi J.A. J. Biol. Chem. 2002; 277: 1928-1932Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar) demonstrated in isolated hearts that metabolic inhibitors activated AMPK to a greater extent than predicted by the measured level of AMP and ATP and suggested that other factors may activate AMPK in the heart. Other studies in various tissues also suggest that AMPK can be activated by mechanisms that do not involve changes in adenine nucleotide levels (6Minokoshi Y. Kim Y.B. Peroni O.D. Fryer L.G. Muller C. Carling D. Kahn B.B. Nature. 2002; 415: 339-343Crossref PubMed Scopus (1660) Google Scholar, 9Hawley S.A. Gadalla A.E. Olsen G.S. Hardie D.G. Diabetes. 2002; 51: 2420-2425Crossref PubMed Scopus (572) Google Scholar, 20Zhou G. Myers R. Li Y. Chen Y. Shen X. Fenyk-Melody J. Wu M. Ventre J. Doebber T. Fujii N. Musi N. Hirshman M.F. Goodyear L.J. Moller D.E. J. Clin. Investig. 2001; 108: 1167-1174Crossref PubMed Scopus (4365) Google Scholar). Another sensor of the metabolic state of the cell is the NAD/NADH redox potential. Studies have shown that a high intracellular NADH/NAD ratio inhibits major metabolic pathways such as glycolysis and fatty acid oxidation (21Williamson J.R. Chang K. Frangos M. Hasan K.S. Idom Y. Kawamura T. Nyengaard J.R. van den Enden M. Kilo C. Tilton R.G. Diabetes. 1993; 42: 801-813Crossref PubMed Scopus (0) Google Scholar). In the present paper, we provide evidence that NAD activates and NADH inhibits the activity of the recombinant AMPK heterotrimeric enzyme. This kind of metabolic regulation might provide an important physiological benefit and an alternative explanation to the activation of AMPK in the absence of changes in adenine nucleotide levels. Reagents—[γ-33P]ATP was purchased from PerkinElmer Life Sciences. All of the other reagents were purchased from Sigma. Plasmid Construction—Co-expression of all three AMPK subunits is required for AMPK enzymatic activity. The α2, β1, and γ1 subunits were amplified from human muscle cDNA by PCR using primers containing a consensus Kozak sequence for proper translation of the gene of interest. The cDNAs were subcloned into the expression vector pPR1, which contains the replication origin (oriP), and a cytomegalovirus promoter. To mimic a phosphorylation state, the catalytic subunit was mutated at threonine 172, the residue that is normally phosphorylated in response to AMP, to an aspartic acid (T172D). α2 T172D was generated using QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). To facilitate downstream detection and purification, a C-terminal FLAG epitope and His tag were incorporated into the β subunit. Expression of Wild Type (WT) and T172D AMPK in 293E Cells—The WT α2 or T172D α2, β1, and γ1 were transiently co-transfected into HEK-293E cells at a 1:1:1 molar ratio using FuGENE 6 (Roche Diagnostics, Indianapolis, IN). Cells were harvested after 48–65 h. The cell lysate was prepared by resuspending cell pellets in M-Per mammalian protein extraction reagent (Pierce) containing 1× EDTA-free complete (Roche Diagnostics), 50 mm NaF, and 5 mm sodium pyrophosphate and spinning at 6000 rpm to remove cell debris. Antibodies to FLAG or gene-specific antibodies were used to detect the expressed protein by Western blot analysis. Purification of T172D and WT AMPK—The kinase was purified to near homogeneity from cell lysates by a single Ni-NTA chromatography, and the three subunits were confirmed with MALDI-MS. NaCl was added to the cell lysate to a final concentration of 150 mm and then incubated with Ni-NTA resin (Qiagen, Valencia, CA) at 4 °C overnight. The resin was collected and packed to a Sephadex G25 XK 50/14 column (Amersham Biosciences). The column was washed with Buffer A (50 mm Tris-HCl, pH 7.5, 1 mm dithiothreitol, 0.02% Brij-35, 10% glycerol) containing 10 mm imidazole. Functional AMPK was eluted from the column with Buffer A containing 500 mm imidazole and concentrated by Centriprep-10 (Millipore, Bedford, MA). The product was desalted using a Sephadex G25 XK 50/14 column and stored frozen in buffer A containing 1 mm EDTA and 1 mm EGTA at –70 °C. The purified recombinant enzyme was active and exhibited AMP-dependent stimulation that was 5–10-fold higher than that of the wild type enzyme. AMPK Assay—AMPK activity was measured in a 96-well filter-binding kinase assay by following the incorporation of 33P into the synthetic SAMS peptide, an AMPK-specific peptide substrate (modified from Hardie et al.) (22Hardie D.G. Haystead T.A.J. Salt I.P. Davies S.P. Assay and Purification of Protein-Serine/Threonine Kinases in Protein Phosphorylation: a Practical Approach Series. Oxford University Press, New York1999: 201-219Google Scholar). The reaction volume was 40 μl and was composed of the following components: 40 mm Hepes-NaOH, pH 7.0, 0.8 mm dithiothreitol, 0.02% Brij-35, and 100 μm AMP; 100 μm SAMS, 100 μm ATP, 10 mm MgCl2,75 mm NaCl, 10 μl of diluted T172D AMPK or WT AMPK per reaction; and 3.3 μCi of [γ-33P]ATP. The reaction was performed at room temperature for 2 h and terminated by the addition of 8 μl of ice-cold 6% phosphoric acid. 40 μl of reaction was transferred onto a 96-well phosphocellulose filter plate (Millipore) followed by washes with 0.75% phosphoric acid and a final rinse with 100 μl of acetone. The filter was air-dried, and 50 μl of Wallac scintillation fluid (OptiPhase”SuperMix,“PerkinElmer Life Sciences) per well was used for counting in a Wallac Microbeta plate counter. Kinetic Model—The model for the rate of peptide phosphorylation, P[t], by AMPK was derived as described by Segel (23Segel I.H. Enzyme Kinetics, Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems. John Wiley & Sons, Inc., New York1975: 330-337Google Scholar) assuming that a rapid equilibrium assumption gives rise to Equations 1, 2, 3, P′[t]=(kcatβKC+kcatCαCn)EtABKN(D1+D2) (Eq. 1) D1=KBα(AKN(Cn+KCβ)γ+KAβ(Cn(KN+N)γ+KC(N+KNγ)))δ (Eq. 2) D2=B(KCβ(AKNγ+KAα(N+KNγ)δ+Cnαγ(AKNδ+KAβ(N+KNδ)))(Eq. 3) where KA, KB, KC, and KN are dissociation constants, n is the Hill coefficient, and α, β, γ, and δ are cooperativity constants (Fig. 5). By dividing P′[t] where NADH (N) concentration equals the IC50 by itself at N equals zero and setting the ratio to 0.5, one can predict the IC50 for NADH at any given ATP (A), peptide (B), and AMP (C) concentration using Equation 4. IC50=KN(KA(B+KB)(Cn+Kc)αβ+A(KBα(Cn+KCβ)+B(Cnα+KC)))γKA(B+KB)αβ(KC+Cnγ) (Eq. 4) The mammalian AMPK is a heterotrimer consisting of a catalytic (α) subunit and two regulatory (β and γ) subunits. To mimic a phosphorylation state, we mutated the catalytic subunit at threonine 172, the residue that is normally phosphorylated in response to AMP, to an aspartic acid (T172D). The WT α2 or T172D-α2, β1, and γ1 cDNAs were transiently co-transfected into HEK-293E cells, and cells were harvested after 48–65 h. The kinase was purified to near homogeneity from cell lysates by single Ni-NTA chromatography. The identities of the three subunits have been confirmed by MALDI-MS. Enzyme activity was assessed by incorporation of [33P]phosphate into the SAMS peptide. The purified recombinant enzymes were active and exhibited AMP-dependent stimulation. The Km for ATP was and for the SAMS peptide, was 100 AMP activated the enzyme with an of whereas for the wild type enzyme was The activity of T172D enzyme was 5–10-fold higher than that of the wild type enzyme not To test whether the redox state might have an effect on AMPK activity, we examined the effect of β-NAD and NADH on this enzyme. the recombinant and the enzymes were activated by β-NAD in a dose-dependent (Fig. 1, A and whereas NADH inhibited its activity (Fig. 1, and the for AMPK activity in the kinase assay was using the enzyme with the we used the enzyme for all of the This activity was not to in the purified recombinant AMPK, this performed with purified from a not any activity. The of NADH to AMPK activity improved in the presence of concentrations of AMP as can be by the IC50 (Fig. In we a effect of AMP on the of NAD to activate AMPK at μm AMP, an in activity was apparent (Fig. We explored the effect of NADH on AMPK by systematically varying ATP, peptide, AMP, and NADH NADH is a that NADH in the ATP or AMP binding and be competitive with respect to one or the apparent ATP competitive behavior with respect to NADH. was was the uncompetitive behavior with respect to AMP as shown in 4. We explored to the upon the established activation of AMPK by AMP S.P. Hardie D.G. FEBS Lett. PubMed Scopus Google Scholar), we proposed the for AMPK regulation by AMP and NADH shown in This model contains a Hill to for the cooperativity as by Hardie et D.G. Salt I.P. Hawley S.A. Davies S.P. Biochem. J. 1999; PubMed Scopus Google Scholar). The of this model are as follows. (a) NADH has an apparent competitive behavior with respect to ATP and apparent uncompetitive with respect to AMP, resulting in binding of NADH to the enzyme in the presence of AMP and peptide. (b) The binding of the peptide to the complex is not significantly In the absence of AMP, the binding constant of NADH becomes higher than physiologically effect of NADH and NAD in the presence of AMP. μm AMP added to the reaction to a significant in the of NAD and NADH to or by AMPK, of effect of ATP on the of AMPK by NADH. The the activity of AMPK as a of ATP and NADH using 50 μm peptide and μm AMP. The ATP concentrations are μm μm 150 μm and μm and the and are the to an IC50 The IC50 from the are shown as in the and are described by a of competitive of NADH with of effect of AMP on the of AMPK by NADH. The the activity of AMPK as a of AMP and NADH using 50 μm peptide and μm ATP. The AMP concentrations are μm μm 5 μm 10 μm and μm and the and are the to an IC50 The IC50 from the are shown in the and are described by the model in of uncompetitive of NADH with AMP. The used in Equation 4 to the in the are as follows. is is is KN is 100 n is 3, α is 1, β is is and δ is AMPK activity cellular in conditions such as muscle and a rapid in W.W. Hardie D.G. Am. J. Physiol. 1999; 277: E1-E10PubMed Google Scholar). its AMPK enzymes to increased oxidation which NADH and ATP are ATP has been shown to the effect of AMP. the that other factors in addition to AMP and ATP might activate or AMPK activity (9Hawley S.A. Gadalla A.E. Olsen G.S. Hardie D.G. Diabetes. 2002; 51: 2420-2425Crossref PubMed Scopus (572) Google Scholar, M. Balschi J.A. J. Biol. Chem. 2002; 277: 1928-1932Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar, 20Zhou G. Myers R. Li Y. Chen Y. Shen X. Fenyk-Melody J. Wu M. Ventre J. Doebber T. Fujii N. Musi N. Hirshman M.F. Goodyear L.J. Moller D.E. J. Clin. Investig. 2001; 108: 1167-1174Crossref PubMed Scopus (4365) Google Scholar). to the of our our for the evidence that NADH inhibits AMPK activity. This also that β-NAD can activate AMPK, at a extent than AMP, and at higher might the activity. The of NAD binding is under studies by Hardie et S.P. Hardie D.G. FEBS Lett. PubMed Scopus Google Scholar) have shown that AMP can activate AMPK by mechanisms including allosteric activation of AMPK, allosteric activation of an upstream and the binding of AMP to AMPK, a substrate for the upstream kinase and a substrate for protein that NAD and NADH AMPK, both the wild type and the phosphorylated we do not have evidence to that have any regulatory effect on an upstream kinase or protein It is to AMPK is activated, NADH, which is by the of oxidation, serves as a of AMPK activity to the of the heart. of substrate oxidation and NADH formation under conditions NADH is high and be to ATP might be The of NADH to AMPK might this Other studies have shown that the intracellular concentration and the ratio increase in muscle L. Mol. Cell. Biochem. 1999; PubMed Scopus Google Scholar). effect of production to increase the NADH/NAD ratio and to the redox may have an important regulatory effect on AMPK activity and AMPK by NADH becomes an in of studies that of AMPK G. I. A. T. Biochem. J. 2003; PubMed Scopus (230) Google Scholar). et C.S. A.S. Life Sci. PubMed Scopus Google Scholar) have shown that stimulation of with high glucose of NADH in the we could that this to of AMPK, which then as was shown to increase NADH/NAD redox state S. Am. J. 2002; PubMed Scopus Google Scholar), the of whether this could be the for the of AMPK activity by in isolated hearts J. Lopaschuk G.D. Full Text PDF PubMed Scopus Google Scholar).
25
Role of AMP-activated protein kinase in mechanism of metformin action
Gaochao Zhou, Robert P. Myers, Ying Li et al. · Journal of Clinical Investigation · 2001 · 5.4K citations
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Yasuhiko Minokoshi, Young‐Bum Kim, Odile D. Peroni et al. · Nature · 2002 · 2K citations
LKB1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade
Angela Woods, Stephen R. Johnstone, Kristina Dickerson et al. · Current Biology · 2003 · 1.6K citations